Syneron Medical Ltd. (ELOS) reported quarterly earnings results on Thursday, May-19-2016. The company said it had a profit of $0.04 Earnings per Share for the quarter. The results exceeded Wall Street expectations beating the analyst consensus estimate by $0.04. Analysts had a consensus of $0.00. The company posted revenue of $68.70 million in the period, compared to analysts expectations of $65.12 million. The company’s revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.02 EPS.
Syneron Medical Ltd. opened for trading at $6.92 and hit $7.19 on the upside on Monday, eventually ending the session at $6.97, with a gain of 1.75% or 0.12 points. The heightened volatility saw the trading volume jump to 78,607 shares. Company has a market cap of $246 M.
Syneron Medical Ltd. is engaged in manufacture research development marketing and sales of advanced equipment for the aesthetic medical industry and systems for dermatologists plastic surgeons and other qualified practitioners. The Company designs develops and markets aesthetic medical products based on its various technologies including Electro-Optical Synergy (ELOS) technology to provide aesthetic medical treatments. The Company’s products targets an array of non-invasive aesthetic medical procedures including hair removal wrinkle reduction rejuvenation of the skin’s appearance through the treatment of superficial benign vascular and pigmented lesions acne treatment treatment of leg veins treatment for the temporary reduction in the appearance of cellulite and thigh circumference ablation and resurfacing of the skin laser-assisted lipolysis and topical skin brightening products.